( en | de | ru )

 

Disambiguierung von "Gessi, S."

Autor der Publikation

KopierenLöschenDiese Publikation zur Ablage hinzufügen
(3)HMRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors

, , , , , , , , , und . Mol Pharmacol, 57 (5): 968-75 (Mai 2000)Varani, K Merighi, S Gessi, S Klotz, K N Leung, E Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Borea, P A United states Molecular pharmacology Mol Pharmacol. 2000 May;57(5):968-75..

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

Andreas Gessinger

Joachim Gessinger

Hartmut Gessinger

Joachim Gessinger

Karlheinz Gessing

 

Weitere Publikationen von Autoren mit dem selben Namen

Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells, , , , , , , , und . J Invest Dermatol, 119 (4): 923-33 (Oktober 2002)Merighi, Stefania Mirandola, Prisco Milani, Daniela Varani, Katia Gessi, Stefania Klotz, Karl-Norbert Leung, Edward Baraldi, Pier Giovanni Borea, Pier Andrea United States The Journal of investigative dermatology J Invest Dermatol. 2002 Oct;119(4):923-33..Synthesis, biological activity, and molecular modeling investigation of new pyrazolo4,3-e-1,2,4-triazolo1,5-cpyrimidine derivatives as human A(3) adenosine receptor antagonists, , , , , , , , , und . J Med Chem, 45 (4): 770-80 (Februar 2002)Baraldi, Pier Giovanni Cacciari, Barbara Moro, Stefano Spalluto, Giampiero Pastorin, Giorgia Da Ros, Tatiana Klotz, Karl-Norbert Varani, Katia Gessi, Stefania Borea, Pier Andrea Research Support, Non-U.S. Gov't United States Journal of medicinal chemistry J Med Chem. 2002 Feb 14;45(4):770-80..Binding thermodynamics at the human A(3) adenosine receptor, , , , , , und . Biochem Pharmacol, 63 (2): 157-61 (Januar 2002)Merighi, Stefania Varani, Katia Gessi, Stefania Klotz, Karl Norbert Leung, Edward Baraldi, Pier Giovanni Borea, Pier Andrea England Biochemical pharmacology Biochem Pharmacol. 2002 Jan 15;63(2):157-61..(3)HMRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors, , , , , , , , , und . Mol Pharmacol, 57 (5): 968-75 (Mai 2000)Varani, K Merighi, S Gessi, S Klotz, K N Leung, E Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Borea, P A United states Molecular pharmacology Mol Pharmacol. 2000 May;57(5):968-75..Adenosine receptors and cancer, , , , , , und . Handb Exp Pharmacol, (2009)Fishman, P Bar-Yehuda, S Synowitz, M Powell, J D Klotz, K N Gessi, S Borea, P A Review Germany Handbook of experimental pharmacology Handb Exp Pharmacol. 2009;(193):399-441..Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, 3HMRE 2029-F20, , , , , , , , , und 2 andere Autor(en). Mol Pharmacol, 67 (6): 2137-47 (Juni 2005)Gessi, Stefania Varani, Katia Merighi, Stefania Cattabriga, Elena Pancaldi, Cecilia Szabadkai, Youri Rizzuto, Rosario Klotz, Karl-Norbert Leung, Edward Mac Lennan, Stephen Baraldi, Pier Giovanni Borea, Pier Andrea Comparative Study United States Molecular pharmacology Mol Pharmacol. 2005 Jun;67(6):2137-47. Epub 2005 Mar 23..Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors, , , , , , , , , und 2 andere Autor(en). Biochem Pharmacol, 70 (11): 1601-12 (November 2005)Varani, Katia Gessi, Stefania Merighi, Stefania Vincenzi, Fabrizio Cattabriga, Elena Benini, Annalisa Klotz, Karl-Norbert Baraldi, Pier Giovanni Tabrizi, Mojgan Aghazadeh Lennan, Stephen Mac Leung, Edward Borea, Pier Andrea England Biochemical pharmacology Biochem Pharmacol. 2005 Nov 25;70(11):1601-12. Epub 2005 Oct 10..Pyrazolo4,3-e1,2,4-triazolo1,5-cpyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen, , , , , , , , , und 1 andere Autor(en). J Med Chem, 43 (25): 4768-80 (Dezember 2000)Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Moro, S Klotz, K N Leung, E Varani, K Gessi, S Merighi, S Borea, P A Research Support, Non-U.S. Gov't United states Journal of medicinal chemistry J Med Chem. 2000 Dec 14;43(25):4768-80..Pyrazolo4,3-e-1,2,4-triazolo1,5-cpyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists, , , , , , , , , und . J Med Chem, 42 (22): 4473-8 (November 1999)Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Klotz, K N Leung, E Varani, K Gessi, S Merighi, S Borea, P A In Vitro Research Support, Non-U.S. Gov't United states Journal of medicinal chemistry J Med Chem. 1999 Nov 4;42(22):4473-8..